Glucagen Hypokit (Glucagon)

Glucagen Hypokit is indicated for the treatment of severe hypoglycemia, particularly when a patient is unable to ingest oral carbohydrates. It is used in emergency situations to quickly raise blood glucose levels.

• Adults and children with insulin‑induced hypoglycemia
• Accidental overdose of antidiabetic agents
• Situations where oral glucose administration is not feasible
• Emergency rescue therapy for diabetic patients experiencing loss of consciousness
• Use by trained caregivers or healthcare professionals in out‑of‑hospital settings

Glucagen Hypokit may cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require immediate medical attention.

Common

• Nausea or vomiting
• Flushing or warmth at the injection site
• Headache
• Dizziness
• Transient rise in blood pressure
• Mild abdominal discomfort

Serious

• Severe allergic reaction (anaphylaxis)
• Rapid heart rate (tachycardia)
• Hypotension
• Persistent vomiting leading to dehydration
• Pancreatitis (rare)
• Severe hyperglycemia if overdosed

Before using Glucagen Hypokit, certain precautions should be considered to ensure safe and effective treatment.

• Verify the diagnosis of hypoglycemia before administration.
• Ensure the product is stored according to label instructions, typically refrigerated but not frozen.
• Do not use if the solution is discolored, cloudy, or contains particles.
• Monitor blood glucose levels after administration to confirm response.
• Seek medical evaluation promptly after use, especially if symptoms persist.
• Use only as directed by a qualified healthcare professional.
• Pregnant or breastfeeding individuals should consult a clinician before use.

Glucagen Hypokit may interact with other medications, affecting its efficacy or safety profile.

Avoid

• Beta‑blockers, which can mask typical signs of hypoglycemia.
• Long‑acting sulfonylureas that may prolong low blood sugar episodes.

Use with caution

• Insulin analogs and rapid‑acting insulin formulations.
• Medications that affect hepatic glycogen storage (e.g., corticosteroids).
• Drugs that influence cardiovascular function, such as calcium channel blockers.
• Alcohol, which can potentiate hypoglycemic effects.
• Any other agents that alter glucose metabolism.